#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Neuroendocrine tumour of the lung Cognitive disorder Anal squamous cell carcinoma Meningitis meningococcal Behcet's syndrome Urea cycle disorder Skin angiosarcoma Myelodysplastic syndrome Myasthenia gravis Post transplant lymphoproliferative disorder Leukoencephalopathy Kidney transplant rejection Cystic fibrosis gastrointestinal disease Uveitis More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Basic Information Pemphigoid – Treatment Cholangitis sclerosing – Life with Disease Choroid melanoma – Trials in Disease Haemophilia B without inhibitors – Trials in Disease Kearns-Sayre syndrome – Trials in Disease Ocular melanoma – Treatment Von Willebrand’s disease – Life with Disease Leiomyosarcoma recurrent – Diagnostics Osteosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Fibrinogen Felzartamab Gskvx000000017033 Iph6501 AZD3632 Spiramycin Venetoclax Gadoquatrane Thymalfasin Piperacillin Sodium Siplizumab Tozinameran Nitrofurantoin Clobetasol Nelarabine Cefazolin Sodium Calcium Folinate Pentahydrate IG-TREGS Clavulanic Acid Trifluridine More therapies…

    Learn about Your Condition

    Anogenital dysplasia Neck pain B-cell lymphoma recurrent Spermatocele Lung adenocarcinoma stage III Ovarian cancer metastatic Frontotemporal dementia Peritoneal abscess Gaucher's disease type III Endometrial stromal sarcoma Lymphoma Infantile apnoea Otitis media Gastric cancer recurrent Angiosarcoma non-metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glycogen storage disease type I

  • Study on Long-Term Safety and Pregnancy Outcomes of Pariglasgene Brecaparvovec in Patients with Glycogen Storage Disease Type Ia (GSDIa)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    Denmark Germany Italy The Netherlands Spain

  • Study on the Effects of Pariglasgene Brecaparvovec for Adults with Glycogen Storage Disease Type Ia

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Glycogen storage disease type I
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    The Netherlands Spain

  • Study of Pariglasgene Brecaparvovec and Prednisolone for Adults with Glycogen Storage Disease Type Ia

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    • Prednisolone
    Denmark Germany Italy The Netherlands Spain

  • Study on the Safety and Effects of mRNA-3745 for Patients with Glycogen Storage Disease Type 1a (GSD1a)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type I
    Investigated Drugs:
    • Ibuprofen Lysine
    • Mrna Encoding Human Glucose-6-Phosphatase Variant S298C
    • Ondansetron Hydrochloride
    France The Netherlands Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!